Proactive Investors - Run By Investors For Investors

AusCann Group releases education resources for medical cannabis awareness

The online education resources aim to bring awareness to medical professionals.
cannabis leaf and green tablets
Yesterday, the company signed a deal with a Columbian medical cannabis company

AusCann Group Holdings Ltd (ASX:AC8) has released a series of online courses for Australian health professionals, as a part of its Medical Outreach Program.

The online education courses aim to support Australian health professionals make informed decisions regarding cannabinoid therapeutics.

AusCann’s chairman Dr Mal Washer said: “It is essential that Australian doctors are informed about the endocannabinoid system and cannabinoid therapeutics so that they can make informed decisions regarding treatment possibilities.

“Until it becomes part of the medical syllabus, there is a need to provide accessible, referenced, objective information about cannabinoid medicines that doctors and other health professionals can draw upon to inform their thinking.”

READ: AusCann Group signs a medical cannabis deal with Columbia based Khiron Life Sciences

AusCann’s chief medical advisor Dr Danial Schecter built an experienced team for the outreach program.

The online courses represent the latest component of that outreach program.

READ: AusCann Group commences trading in the US increasing global exposure

AusCann recently commenced trading on the US OTCQX Market under the stock symbol ACNNF.

Trading on the OTCQX supports AusCann’s strategy to broaden its international investor base, particularly in North America where it has a number of strategic agreements in place.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full AC8 profile View Profile

AusCann Group Holdings Ltd Timeline

Related Articles

Cannabis leaf
November 19 2018
With the legalisation of recreational cannabis in Canada in October, and the US expected to follow suit, the company has its sights set on building up the very best in the industry
1542134062_Harvesting-hemp.jpg
November 14 2018
Ascent, viaThirty Eight Hemp Corp, will exploit the hemp market via its strategic relationship with AgTech Scientific
The R&D programme is intended to address the increasing prevalence of obesity and diabetes using smart siRNA
October 31 2018
The health sciences company noted that the plan was formulated at a recently held two-day intensive workshop which together leading scientific teams from the QIMR Berghofer Medical Research Institute in Brisbane and Murdoch University in Perth

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use